HUB Organoids (HUB) is the global leader in the field of adult stem cell-derived organoids.
HUB´s Organoid Technology represents a paradigm shift for drug discovery and development, preclinical patient stratification, predictive diagnostics, personalized medicine, clinical trials, regenerative medicine, and companion diagnostics.
HUB offers licenses to its proprietary technology and provides services its organoid biobank.
Company Details
- Employees
- 74
- Founded
- -
- Address
- Yalelaan 62, Utrecht,nederland 3584 Cm,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- huborganoids.nl
- Keywords
- Organoid Technology, Drug-screening, Living Biobank, Predictive Diagnostics, Companion Diagnostics, Drug discovery and development.
- HQ
- Utrecht, Nederland
Hub Organoids Questions
Hub Organoids's website is huborganoids.nl
Hub Organoids's LinkedIn profile is https://nl.linkedin.com/company/huborganoids
Hub Organoids has
74 employees.
View email and phone details for 74
employees at Hub Organoids.
Hub Organoids's industry is
Biotechnology Research
Hub Organoids's top competitors are
Alveolix,
Mimetas,
Ncardia,
Bi/ond,
Tissuse Gmbh,
Hubrecht Institute,
Insphero,
Emulate, Inc.,
4dcell,
Genmab.
Hub Organoids's categories are Biotechnology Research
Hub Organoids's founding year is 2013
